Clinical Trial

COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate whether the A118G single-nucleotide polymorphism (SNP) in the mu-opioid receptor1(OPRM1) and Catechol-O-methyltransferase (COMT) SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries. The main question\[s\] it aims to answer \[is\]: Do OPRM1 and COMT SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries? Participants will be assessed for their pain scores, sedation level, the amount of postoperative analgesics received, duration of their stay in the post-anesthesia care unit, and toxicity.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-10.
Status change: Not Yet Recruiting → Recruiting 2025-03-14
Trial Details
NCT Number NCT06777875
Lead Sponsor American University of Beirut Medical Center
Conditions Pain, Genetic Change, Children, Only
Enrollment 200 participants
Start Date 2025-03-10
Primary Completion 2027-01-13 (estimated)
Study Completion 2027-01-13 (estimated)
Updated on ClinicalTrials.gov 2025-03-18